CD44 and ovarian carcinoma: This nanotechnological system showed high therapeutic potential for the targeted treatment of ovarian carcinoma with a novel DDS that effectively and simultaneously transports a drug combination containing siRNA targeting CD44 mRNA and cytotoxic agents [85].